ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Geriatric Medicine

Top Geriatric Medicine Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH ANQUILLARE M.D.

Geriatric Medicine

32,153

$1.76M

616
568 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $59

ARCANGELO DISTEFANO MD

Geriatric Medicine

16,738

$981K

563
498 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $59

PASQUALE MASONE MD

Geriatric Medicine

15,946

$953K

543
451 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $59

ANN DATUNASHVILI M.D.

Geriatric Medicine

14,595

$850K

313
275 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $59

DANIEL WOLLMAN M.D, PHD

Geriatric Medicine

13,025

$696K

329
278 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

STUART MILLER M.D.

Geriatric Medicine

12,929

$798K

564
512 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $59

WILFRED ELABA M.D.

Geriatric Medicine

11,402

$564K

218
203 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $59

EDWARD BERMAN M.D.

Geriatric Medicine

9,928

$620K

409
313 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $59

JACQUELINE HENCHEL M.D.

Geriatric Medicine

9,893

$514K

211
203 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $59

LEEN BAKKALI MD

Geriatric Medicine

9,628

$612K

200
193 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $59

MARIA STACK M.D.

Geriatric Medicine

8,896

$638K

410
361 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $59

PAMELA HOFFMAN MD

Geriatric Medicine

8,259

$502K

167
144 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $59

CASEY OTT M.D.

Geriatric Medicine

8,245

$502K

725
697 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $59

MITHIL CHOKSEY M.D.

Geriatric Medicine

8,103

$413K

220
216 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $59

JUDY MAMACLAY MD

Geriatric Medicine

8,028

$479K

245
220 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $59

OLUSEGUN APOESO MD

Geriatric Medicine

7,756

$355K

208
206 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $59

MUHAMMED QURESHI MD

Geriatric Medicine

7,569

$514K

363
174 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $59

ROBERT DICKS M.D.

Geriatric Medicine

7,528

$434K

259
251 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $59

FREDERICK ROWLAND MD

Geriatric Medicine

7,467

$309K

247
241 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $59

MARINA BLAGODATNY MD

Geriatric Medicine

7,063

$494K

217
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $59

JOSEPH HERBIN MD

Geriatric Medicine

6,349

$348K

261
242 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $59

ARNOLD DOROSARIO M.D.

Geriatric Medicine

5,993

$404K

590
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $59

KAREN MAGNUSON M.D.

Geriatric Medicine

5,693

$436K

107
106 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$77
Average prescription price

Avg: $59

MAUREEN DANA MD

Geriatric Medicine

5,644

$270K

122
120 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $59

CHRISTIAN HEINEKEN MD

Geriatric Medicine

5,550

$294K

332
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank